α-synuclein induced synapse damage is enhanced by amyloid- 1-42

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Bate, Clive ^a   Gentleman, Steve ^b   Williams, Alun ^a,c  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; FLUORESCENT DYE; FM 143; PRION PROTEIN; PRP 82 146 PROTEIN; RECOMBINANT ALPHA SYNUCLEIN; RECOMBINANT PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; INCUBATION TIME; MOUSE; NERVE CELL; NERVE CELL CULTURE; NERVE CELL LESION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PROTEIN PROTEIN INTERACTION; SYNAPSE; SYNAPSE VESICLE; SYNAPTIC MEMBRANE;

EID: 78649740289     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-55     Document Type: Article

References (56)

1. Non-motor symptoms in Parkinson's disease. W Poewe, Eur J Neurol 2008 15 Suppl 1 14 20 10.1111/j.1468-1331.2008.02056.x 18353132
2. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. D Aarsland K Andersen JP Larsen A Lolk P Kragh-Sorensen, Arch Neurol 2003 60 3 387 392 10.1001/archneur.60.3.387 12633150
3. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. IG McKeith DW Dickson J Lowe M Emre JT O'Brien H Feldman J Cummings JE Duda C Lippa EK Perry,, et al. Neurology 2005 65 12 1863 1872 10.1212/01.wnl.0000187889.17253.b1 16237129
4. Snaring the function of alpha-synuclein. NM Bonini BI Giasson, Cell 2005 123 3 359 361 10.1016/j.cell.2005.10.017 16269324
5. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. DE Cabin K Shimazu D Murphy NB Cole W Gottschalk KL McIlwain B Orrison A Chen CE Ellis R Paylor,, et al. J Neurosci 2002 22 20 8797 8807 12388586
6. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. DF Clayton JM George, Trends Neurosci 1998 21 6 249 254 10.1016/S0166-2236(97)01213-7 9641537
7. Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease. AG Kazantsev AM Kolchinsky, Arch Neurol 2008 65 12 1577 1581 10.1001/archneur.65.12.1577 19064744
8. Presynaptic -Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies. ML Kramer WJ Schulz-Schaeffer, J Neurosci 2007 27 6 1405 1410 10.1523/JNEUROSCI.4564-06.2007 17287515
9. Mechanisms of Parkinson's Disease Linked to Pathological [alpha]-Synuclein: New Targets for Drug Discovery. VMY Lee JQ Trojanowski, Neuron 2006 52 1 33 38 10.1016/j.neuron.2006.09.026 17015225
10. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of -synuclein. P Desplats H-J Lee E-J Bae C Patrick E Rockenstein L Crews B Spencer E Masliah S-J Lee, Proc Natl Acad Sci USA 2009 106 31 13010 13015 10.1073/pnas.0903691106 19651612
11. Prion-like transmission of protein aggregates in neurodegenerative diseases. P Brundin R Melki R Kopito, Nat Rev Mol Cell Biol 2010 11 4 301 307 10.1038/nrm2873 20308987
12. Staging of brain pathology related to sporadic Parkinson's disease. H Braak K Del Tredici U Rub RA de Vos EN Jansen Steur E Braak, Neurobiol Aging 2003 24 2 197 211 10.1016/S0197-4580(02)00065-9 12498954
13. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. JE Galvin K Uryu VM Lee JQ Trojanowski, Proc Natl Acad Sci USA 1999 96 23 13450 13455 10.1073/pnas.96.23. 13450 10557341
14. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. CY Chung JB Koprich H Siddiqi O Isacson, J Neurosci 2009 29 11 3365 3373 10.1523/JNEUROSCI.5427-08.2009 19295143
15. Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro. C Bate M Tayebi M Salmona L Diomede A Williams, Neurotox Res 2010 17 3 203 214 10.1007/s12640-009-9093-2 19644728
16. Synaptic vesicle proteins and regulated exocytosis. LA Elferink RH Scheller, J Cell Sci 1993 17 75 79
17. Synaptophysin regulates clathrin-independent endocytosis of synaptic vesicles. C Daly M Sugimori JE Moreira EB Ziff R Llinas, Proc Natl Acad Sci USA 2000 97 11 6120 6125 10.1073/pnas.97.11.6120 10823955
18. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. PH Reddy G Mani BS Park J Jacques G Murdoch W Whetsell Jr. J Kaye M Manczak, J Alzheimers Dis 2005 7 2 103 117 15851848
19. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. SE Counts M Nadeem SP Lad J Wuu EJ Mufson, J Neuropath Exp Neurol 2006 65 6 592 601 10.1097/00005072-200606000-00007 16783169
20. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. E Masliah RD Terry M Alford R DeTeresa LA Hansen, Am J Path 1991 138 1 235 246 1899001
21. 2and Synapse Degeneration. C Bate A Williams, J Alzheimers Dis 2010 21 3 985 993 20634578
22. -Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. M Hashimoto E Rockenstein M Mante M Mallory E Masliah, Neuron 2001 32 2 213 223 10.1016/S0896-6273(01)00462-7 11683992
23. Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. JY Park PT Lansbury Jr, Biochemistry 2003 42 13 3696 3700 10.1021/bi020604a 12667059
24. A-Generating Enzymes: Recent Advances in and -Secretase Research. R Vassar M Citron, Neuron 2000 27 3 419 422 10.1016/S0896-6273(00)00051-9 11055423
25. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. J Hardy DJ Selkoe, Science 2002 297 5580 353 356 10.1126/science.1072994 12130773
26. Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. BA Yankner T Lu, JBiolChem 2009 284 8 4755 4759
27. Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases. IF Tsigelny L Crews P Desplats GM Shaked Y Sharikov H Mizuno B Spencer E Rockenstein M Trejo O Platoshyn,, et al. PLoS ONE 2008 3 9 3135 10.1371/journal.pone.0003135 18769546
28. Interaction between A Peptide and Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer's and Parkinson's in Dementia with Lewy Body Disease. P Mandal J Pettegrew E Masliah R Hamilton R Mandal, Neurochem Res 2006 31 9 1153 1162 10.1007/s11064-006-9140-9 16947080
29. 1-42/1-40ratio in vitro and in vivo. DR Borchelt G Thinakaran CB Eckman MK Lee F Davenport T Ratovitsky CM Prada G Kim S Seekins D Yager,, et al. Neuron 1996 17 5 1005 1013 10.1016/S0896-6273(00)80230-5 8938131
30. Evidence that production and release of amyloid -protein involves the endocytic pathway. EH Koo SL Squazzo, JBiolChem 1994 269 26 17386 17389
31. Aggregation of secreted amyloid -protein into sodium dodecyl sulfate-stable oligomers in cell culture. MB Podlisny BL Ostaszewski SL Squazzo EH Koo RE Rydell DB Teplow DJ Selkoe, JBiolChem 1995 270 16 9564 9570
32. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. M Jeffrey WG Halliday J Bell AR Johnston NK MacLeod C Ingham AR Sayers DA Brown JR Fraser, Neuropath Appl Neurobiol 2000 26 1 41 54 10.1046/j.1365-2990.2000.00216.x (Pubitemid 30145305)
33. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. I Ferrer, Cerebellum 2002 1 3 213 222 10.1080/14734220260418448 12879983
34. beta-Synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein. E Israeli R Sharon, J Neurochem 2009 108 2 465 474 10.1111/j.1471-4159.2008.05776.x 19012742
35. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. L Hansen D Salmon D Galasko E Masliah R Katzman R DeTeresa L Thal MM Pay R Hofstetter M Klauber,, et al. Neurology 1990 40 1 1 8 2153271
36. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. CF Lippa H Fujiwara DM Mann B Giasson M Baba ML Schmidt LE Nee B O'Connell DA Pollen P St George-Hyslop,, et al. Am J Pathol 1998 153 5 1365 1370 9811326
37. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. JQ Trojanowski M Goedert T Iwatsubo VM Lee, Cell Death Differ 1998 5 10 832 837 10.1038/sj.cdd.4400432 10203692
38. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. RL Hamilton, Brain Pathol 2000 10 3 378 384 10.1111/j.1750-3639.2000.tb00269.x 10885656
39. Amyloid- protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. GM Shankar S Li TH Mehta A Garcia-Munoz NE Shepardson I Smith FM Brett MA Farrell MJ Rowan CA Lemere,, et al. Nat Med 2008 14 8 837 842 10.1038/nm1782 18568035
40. Oligomerization of Alzheimer's -Amyloid within Processes and Synapses of Cultured Neurons and Brain. RH Takahashi CG Almeida PF Kearney F Yu MT Lin TA Milner GK Gouras, J Neurosci 2004 24 14 3592 3599 10.1523/JNEUROSCI.5167-03.2004 15071107
41. Naturally secreted oligomers of amyloid protein potently inhibit hippocampal long-term potentiation in vivo. DM Walsh I Klyubin JV Fadeeva WK Cullen R Anwyl MS Wolfe MJ Rowan DJ Selkoe, Nature 2002 416 6880 535 539 10.1038/416535a 11932745
42. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease. A Iwai E Masliah MP Sundsmo R DeTeresa M Mallory DP Salmon T Saitoh, Brain Res 1996 720 1-2 230 234 10.1016/0006-8993(96)00014-5 8782917 (Pubitemid 26179830)
43. Role of Synucleins in Alzheimer's Disease. L Crews I Tsigelny M Hashimoto E Masliah, Neurotoxicity Res 2009 16 3 306 317 10.1007/s12640-009-9073-6
44. -amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. E Masliah E Rockenstein I Veinbergs Y Sagara M Mallory M Hashimoto L Mucke, Proc Natl Acad Sci USA 2001 98 21 12245 12250 10.1073/pnas.211412398 11572944
45. Oligomeric and Fibrillar Species of Amyloid- Peptides Differentially Affect Neuronal Viability. KN Dahlgren AM Manelli WB Stine Jr. LK Baker GA Krafft MJ LaDu, JBiolChem 2002 277 35 32046 32053
46. Neurodegeneration induced by -amyloid peptides in vitro: the role of peptide assembly state. CJ Pike D Burdick AJ Walencewicz CG Glabe CW Cotman, J Neurosci 1993 13 4 1676 1687 8463843
47. 1-42are potent central nervous system neurotoxins. MP Lambert AK Barlow BA Chromy C Edwards R Freed M Liosatos TE Morgan I Rozovsky B Trommer KL Viola,, et al. Proc Natl Acad Sci USA 1998 95 11 6448 6453 10.1073/pnas.95.11.6448 9600986
48. A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease. PN Lacor MC Buniel PW Furlow A Sanz Clemente PT Velasco M Wood KL Viola WL Klein, J Neurosci 2007 27 4 796 807 10.1523/JNEUROSCI.3501-06.2007 17251419
49. Natural Oligomers of the Alzheimer Amyloid- Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway. GM Shankar BL Bloodgood M Townsend DM Walsh DJ Selkoe BL Sabatini, J Neurosci 2007 27 11 2866 2875 10.1523/JNEUROSCI.4970-06.2007 17360908
50. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide. C Haass DJ Selkoe, Nat Rev Mol Cell Biol 2007 8 2 101 112 10.1038/nrm2101 17245412
51. Generation of an Apoptotic Intracellular Peptide by -Secretase Cleavage of Alzheimer's Amyloid Protein Precursor. B Passer L Pellegrini C Russo RM Siegel MJ Lenardo G Schettini M Bachmann M Tabaton L D'Adamio, JAlzheimersDis 2000 2 289 301
52. Secreted amyloid -protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. D Scheuner C Eckman M Jensen X Song M Citron N Suzuki TD Bird J Hardy M Hutton W Kukull,, et al. Nat Med 1996 2 8 864 870 10.1038/nm0896-864 8705854
53. Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein. M Salmona M Morbin T Massignan L Colombo G Mazzoleni R Capobianco L Diomede F Thaler L Mollica G Musco,, et al. JBiolChem 2003 278 48 48146 48153
54. Isolation and culture of adult rat hippocampal neurons. GJ Brewer, J Neurosci Meth 1997 71 2 143 155 10.1016/S0165-0270(96)00136-7 (Pubitemid 27152111)
55. Kinetics and regulation of fast endocytosis at hippocampal synapses. J Klingauf ET Kavalali RW Tsien, Nature 1998 394 6693 581 585 10.1038/29079 9707119
56. Synaptosomal glutamate release and uptake in mice lacking the cellular prion protein. ME Thais CL Carqueja TG Santos RV Silva E Stroeh RS Machado DO Wahlheim MM Bianchin AC Sakamoto RR Brentani,, et al. Brain Res 2006 1075 1 13 19 10.1016/j.brainres.2005.12.045 16519879